Behnam Sadeghi

2.1k total citations
67 papers, 1.6k citations indexed

About

Behnam Sadeghi is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Behnam Sadeghi has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 22 papers in Genetics and 19 papers in Immunology. Recurrent topics in Behnam Sadeghi's work include Hematopoietic Stem Cell Transplantation (28 papers), Mesenchymal stem cell research (22 papers) and Immune Cell Function and Interaction (11 papers). Behnam Sadeghi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Mesenchymal stem cell research (22 papers) and Immune Cell Function and Interaction (11 papers). Behnam Sadeghi collaborates with scholars based in Sweden, Iran and Germany. Behnam Sadeghi's co-authors include Moustapha Hassan, Olle Ringdén, Guido Moll, Slavica Brnjic, Paola Perego, Stig Linder, Michelandrea De Cesare, Rolf Larsson, Maria Hägg Olofsson and Kristina Lindsten and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Behnam Sadeghi

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behnam Sadeghi Sweden 21 598 433 395 312 286 67 1.6k
Yue Han China 22 934 1.6× 185 0.4× 550 1.4× 391 1.3× 367 1.3× 193 2.3k
Roberto Conte Italy 25 684 1.1× 289 0.7× 704 1.8× 357 1.1× 504 1.8× 81 2.1k
Steven P. Grover United States 23 748 1.3× 251 0.6× 665 1.7× 221 0.7× 568 2.0× 57 2.5k
Silvia Cantoni Italy 21 503 0.8× 448 1.0× 275 0.7× 211 0.7× 111 0.4× 75 1.6k
Julie Rayes United Kingdom 21 405 0.7× 172 0.4× 696 1.8× 349 1.1× 562 2.0× 45 1.7k
Hanshi Xu China 30 1.0k 1.7× 140 0.3× 197 0.5× 328 1.1× 568 2.0× 80 2.4k
Diana Bugarski Serbia 23 526 0.9× 526 1.2× 77 0.2× 249 0.8× 303 1.1× 79 1.6k
C. Darrell Jennings United States 20 450 0.8× 257 0.6× 707 1.8× 299 1.0× 602 2.1× 58 1.8k
Soledad Negrotto Argentina 26 766 1.3× 128 0.3× 538 1.4× 231 0.7× 791 2.8× 48 2.0k
Carsten Deppermann Germany 21 438 0.7× 141 0.3× 469 1.2× 186 0.6× 518 1.8× 31 1.7k

Countries citing papers authored by Behnam Sadeghi

Since Specialization
Citations

This map shows the geographic impact of Behnam Sadeghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behnam Sadeghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behnam Sadeghi more than expected).

Fields of papers citing papers by Behnam Sadeghi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behnam Sadeghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behnam Sadeghi. The network helps show where Behnam Sadeghi may publish in the future.

Co-authorship network of co-authors of Behnam Sadeghi

This figure shows the co-authorship network connecting the top 25 collaborators of Behnam Sadeghi. A scholar is included among the top collaborators of Behnam Sadeghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behnam Sadeghi. Behnam Sadeghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barough, Mahdieh Shokrollahi, Amir Seyfoori, Esfandyar Askari, et al.. (2024). Gemcitabine‐Loaded Injectable Hydrogel for Localized Breast Cancer Immunotherapy. Advanced Functional Materials. 34(41). 15 indexed citations
2.
Ringdén, Olle & Behnam Sadeghi. (2024). Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease. Stem Cells. 42(4). 291–300. 4 indexed citations
3.
Zeiser, Robert, et al.. (2023). Novel therapies for graft versus host disease with a focus on cell therapies. Frontiers in Immunology. 14. 1241068–1241068. 11 indexed citations
4.
Ringdén, Olle, Elham Roshandel, Mohammad Mahdi Majidi, et al.. (2022). Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells. Transplantation and Cellular Therapy. 28(3). S222–S222. 1 indexed citations
5.
Soleimani, Masoud, et al.. (2022). Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID‐19 infection: A case report. SHILAP Revista de lepidopterología. 10(5). e05851–e05851. 2 indexed citations
6.
Mohammadi, Javad, Katharina Maniura‐Weber, Berna Şentürk, et al.. (2019). Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid. Biomaterials Science. 8(1). 148–162. 24 indexed citations
7.
Sadeghi, Behnam, et al.. (2019). Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells. International Journal of Hematology. 111(4). 591–594. 4 indexed citations
8.
Sadeghi, Behnam, Fabian Arnberg, Erik Samén, et al.. (2019). Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells. Frontiers in Immunology. 10. 2685–2685. 25 indexed citations
9.
Baygan, Arjang, Göran Dahllöf, Lena Klingspor, et al.. (2017). Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. Frontiers in Immunology. 8. 795–795. 39 indexed citations
10.
Ringdén, Olle, et al.. (2017). Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. International Journal of Hematology. 107(4). 478–485. 10 indexed citations
11.
Moll, Guido, Lech Ignatowicz, Rusan Catar, et al.. (2015). Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placenta Decidua. Transplant International. 28. 50–51. 2 indexed citations
12.
Moll, Guido, Lech Ignatowicz, Rusan Catar, et al.. (2015). Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua. Stem Cells and Development. 24(19). 2269–2279. 99 indexed citations
13.
Kaipe, Helen, Tom Erkers, Silvia Nava, et al.. (2015). Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients. Stem Cells and Development. 24(12). 1471–1482. 17 indexed citations
14.
Kaipe, Helen, Tom Erkers, Behnam Sadeghi, & Olle Ringdén. (2014). Stromal cells–are they really useful for GVHD?. Bone Marrow Transplantation. 49(6). 737–743. 30 indexed citations
15.
Boels, P. J., Fahad Zadjali, Behnam Sadeghi, et al.. (2012). Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase. PLoS ONE. 7(1). e30897–e30897. 35 indexed citations
16.
Abdollahı, Mohammad, et al.. (2008). Studies on potential mutagenic and genotoxic activity of Setarud. DARU Journal of Pharmaceutical Sciences. 16(4). 223–228. 19 indexed citations
17.
Borhani‐Haghighi, Afshin, et al.. (2008). EFFECT OF ANGIPARS™, A NEW HERBAL DRUG ON DIABETIC FOOT ULCER: A PHASE 2 CLINICAL STUDY. DARU Journal of Pharmaceutical Sciences. 16(1). 31–44. 20 indexed citations
18.
Sadeghi, Behnam, et al.. (2008). In vivo and in vitro genotoxicity studies of Semelil (ANGIPARS. DARU Journal of Pharmaceutical Sciences. 16(1). 20–24. 22 indexed citations
19.
Sadeghi, Behnam, et al.. (2003). Effects of passive smoking on common respiratory symptoms in young children. Acta Paediatrica. 92(12). 1394–1397. 7 indexed citations
20.
Haidari, Mehran, et al.. (2001). Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease.. Clinical Biochemistry. 34(4). 309–315. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026